Similar results were obtained by Cox et al., who reported that CD200 was overexpressed in B-ALL cases compared to cord blood (CB) samples (54.6% ± 8.1% vs. 0.07 ± 0.09%, respectively, p = 0.0002) [8]. The gene discussed is CD200; the disease is precursor B-cell acute lymphoblastic leukemia.